510(k) Report

PMA · Approved

Approved

InterStim™ Therapy System, Verify™ Evaluation System

P970004/S455PMAApproved Aug 8, 202629-day reviewClass III21 CFR 876.5270

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Neuromodulation · EZW Stimulator, Electrical, Implantable, For Incontinence

Approved on Aug 8, 2026 through premarket approval, which rests on the device’s own clinical evidence after a 29-day review.

Decided
Aug 8, 2026
Review
29 days
Class
Class III
Product code
EZW
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

FIG. 1 — Lineage of P970004/S455Source: FDA PMA database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in EZW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All EZW devices

EZW Stimulator, Electrical, Implantable, For Incontinence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · EZW

36in 2025

2007: 62008: 142009: 122010: 242011: 262012: 192013: 172014: 232015: 202016: 272017: 272018: 192019: 242020: 432021: 342022: 462023: 322024: 352025: 362026 (partial year): 37
2007high 46 (2022) · low 6 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · EZW

Too few EZW 510(k)s in any year since 2007 to give a median.

Recalls per year · EZW

1in 2024

2007: 22008: 12021: 12022: 12024: 12026 (partial year): 1
2007high 2 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · EZW

6,956in 2025

2007: 1682008: 7242009: 1,0122010: 1,4252011: 1,6102012: 2,8152013: 3,7362014: 4,6032015: 5,9772016: 7,0832017: 8,0972018: 5,7372019: 4,7722020: 4,1182021: 4,4792022: 4,3182023: 5,0562024: 5,7732025: 6,956
2007high 8,097 (2017) · low 168 (2007)2025

MAUDE reports naming product code EZW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076—2168
200814—1724
200912—01,012
201024—01,425
201126—01,610
201219—02,815
201317—03,736
201423—04,603
201520—05,977
201627—07,083
201727—08,097
201819—05,737
201924—04,772
202043—04,118
202134—14,479
202246—14,318
202332—05,056
202435—15,773
202536—06,956
202637—1—
Cite this page

510(k) Report. “P970004/S455: InterStim™ Therapy System, Verify™ Evaluation System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P970004/S455

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Page last updated Nov 3, 2026